TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Spago Nanomedical AB (publ)
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 | 2021/12 |
| Turnover |
108
|
95
|
65 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-3,805
|
-3,522
|
-3,820 |
| EBITDA |
-3,857
|
-3,514
|
-3,795 |
| Total assets |
4,775
|
18,507
|
18,737 |
| Current assets |
4,678
|
5,863
|
5,318 |
| Current liabilities |
1,034
|
791
|
666 |
| Equity capital |
3,724
|
17,717
|
18,071 |
| - share capital |
1,700
|
8,172
|
4,027 |
| Employees (average) |
13
|
15
|
16 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
| Solvency |
78.0%
|
95.7%
|
96.4% |
| Turnover per employee |
8
|
6
|
4 |
| Profit as a percentage of turnover |
-3523.1%
|
-3707.4%
|
-5876.9% |
| Return on assets (ROA) |
-79.7%
|
-19.0%
|
-20.4% |
| Current ratio |
452.4%
|
741.2%
|
798.5% |
| Return on equity (ROE) |
-102.2%
|
-19.9%
|
-21.1% |
| Change turnover | |||
| Change turnover % |
60%
|
93% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
-6%
|
7% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.